Navigating, Pricing, Reimbursement and Fraud and Abuse Risks for Drugs, Devices and Combination products
This CLE program will provide an overview of fraud and abuse and government pricing regulations applicable to pharmaceutical and medical device manufacturers. This program will include a brief overview of the Federal Anti-Kickback, the False Claims Act, government pricing obligations under Medicaid, Medicare Part B, the Veterans Affairs program, the 340B drug discount program, as well as recent examples of enforcement trends. All RSVPS must be made by 5 p.m. et on December 10 to Emilie Lawson at 202-942-6712. This program has been approved for 1 hour of CA MCLE credit.